Last update 31 May 2025

DY-16-43

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
DY-16-43
Target
NOD2
Action
antagonists
Mechanism
NOD2 antagonists(Nucleotide-binding oligomerization domain-containing protein 2 antagonists)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Neoplasms
Originator Organization
Tsinghua UniversityTsinghua University
Active Organization-
Inactive Organization
Tsinghua UniversityTsinghua University
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC73H86ClN7O20
InChIKeyDWEFKVFXMLTKPV-AWYNESNJSA-N
CAS Registry2068145-38-8

Related

100 Clinical Results associated with DY-16-43
Login to view more data
100 Translational Medicine associated with DY-16-43
Login to view more data
100 Patents (Medical) associated with DY-16-43
Login to view more data
1
Literatures (Medical) associated with DY-16-43
09 Feb 2017Journal of medicinal chemistryQ1 · MEDICINE
Antagonizing NOD2 Signaling with Conjugates of Paclitaxel and Muramyl Dipeptide Derivatives Sensitizes Paclitaxel Therapy and Significantly Prevents Tumor Metastasis
Q1 · MEDICINE
100 Deals associated with DY-16-43
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
China
Tsinghua UniversityTsinghua University
09 Feb 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free